ALGS vs IRM · rev $3.6M vs P/E 136, rev $6.15B
Aligos Therapeutics Inc (ALGS) versus Iron Mountain Incorporated (IRM) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
Iron Mountain Incorporated (IRM) is a reit - specialty company listed on US.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
Latest reported IRM revenue for 2024-12-31 was $6.15B. Net income was $183.7M. Revenue was up 12.2% from 2023-12-31 to 2024-12-31. IRM currently screens at market cap $37.09B and trailing P/E 135.5.
ALGS currently screens at market cap $44.1M. IRM currently screens at market cap $37.09B and trailing P/E 135.5.
Not investment advice. Open the ALGS and IRM stock pages for the full models.
Not investment advice.